Anticoagulant activity in salivary glands of the insect vector Culicoides variipennis sonorensis by an inhibitor of factor Xa

被引:19
|
作者
de León, AAP [1 ]
Valenzuela, JG
Tabachnick, WJ
机构
[1] USDA ARS, Arthropod Borne Anim Dis Res Lab, Laramie, WY 82071 USA
[2] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA
[3] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA
关键词
insect vector; blood feeding; salivary glands; blood coagulation; anticoagulant; Culicoides variipennis sonorensis; activated form of coagulation factor 10 (FXa); FXa inhibitor;
D O I
10.1006/expr.1998.4210
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Blood feeding by the insect vector Culicoides variipennis sonorensis involves laceration of superficial host tissues, an injury that would be expected to trigger the coagulation cascade. Accordingly, the salivary glands of C.v. sonorensis were examined for the presence of an antihemostatic that prevents blood coagulation. Assays using salivary gland extracts showed a delay in the recalcification time of plasma devoid of platelets, indicating the presence of anticoagulant activity. Retardation in the formation of a fibrin clot was also observed after the addition of tissue factor to plasma that was preincubated with salivary gland extracts. Similarly, an inhibitory effect by salivary gland extracts was detected in assays that included factors of the intrinsic pathway. Inhibition of the catalytic activity of purified factor Xa toward its chromogenic subtrate suggested that it was the target of the salivary anticoagulant of C. v. sonorensis. This was corroborated by the coincidence of anticoagulant and anti-FXa activities obtained by reverse-phase HPLC. The depletion of anti-FXa activity from salivary glands during blood feeding suggests that the FXa inhibitor functions as anticoagulant. Molecular sieving HPLC yielded an apparent molecular mass of 28 kDa for the salivary FXa inhibitor of C.v. sonorensis. Preventing the formation of thrombin through the inhibition of FXa likely facilitates blood feeding by maintaining the pool of blood fluid at the feeding site. The salivary FXa inhibitor of C.v. sonorensis could impair the network of host-defense mechanisms in the skin microenvironment by avoiding blood coagulation at the site of feeding. (C) 1998 Academic Press.
引用
收藏
页码:121 / 130
页数:10
相关论文
共 50 条
  • [41] ANTIPROTEASIC ACTIVITY OF INHIBITOR FROM DOG SUBMANDIBULAR SALIVARY-GLANDS
    STEFANOV, OV
    UKRAINSKII BIOKHIMICHESKII ZHURNAL, 1975, 47 (02): : 165 - 168
  • [42] Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays
    Hillarp, Andreas
    Strandberg, Karin
    Baghaei, Fariba
    Blixter, Inger Fagerberg
    Gustafsson, Kerstin M.
    Lindahl, Tomas L.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2018, 78 (7-8): : 575 - 583
  • [43] DX-9065A, A NEW SYNTHETIC, POTENT ANTICOAGULANT AND SELECTIVE INHIBITOR FOR FACTOR-XA
    HARA, T
    YOKOYAMA, A
    ISHIHARA, H
    YOKOYAMA, Y
    NAGAHARA, T
    IWAMOTO, M
    THROMBOSIS AND HAEMOSTASIS, 1994, 71 (03) : 314 - 319
  • [44] DX-9065a, a specific factor Xa inhibitor, as a universal anticoagulant for blood collection tubes
    Kumura, T
    Hino, M
    Yamane, T
    Tominaga, K
    Tatsumi, N
    CLINICA CHIMICA ACTA, 2000, 294 (1-2) : 27 - 35
  • [45] TICK ANTICOAGULANT PEPTIDE (TAP) IS A NOVEL INHIBITOR OF BLOOD-COAGULATION FACTOR-XA
    WAXMAN, L
    SMITH, DE
    ARCURI, KE
    VLASUK, GP
    SCIENCE, 1990, 248 (4955) : 593 - 596
  • [46] Anticoagulant activities of EP42675, synthetic direct thrombin and indirect factor Xa inhibitor
    Sollier, Bal Dit C.
    Neuhart, E.
    Krezel, C.
    Petitou, M.
    Drouet, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 376 - 377
  • [47] A Novel Prothrombin Time Assay for Assessing the Anticoagulant Activity of Oral Factor Xa Inhibitors
    Barrett, Yu Chen
    Wang, Zhaoqing
    Knabb, Robert M.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (05) : 522 - 528
  • [48] Novel syntheses of Idraparinux, the anticoagulant pentasaccharide with indirect selective factor Xa inhibitory activity
    Herczeg, Mihaly
    Mezo, Erika
    Lazar, Laszlo
    Fekete, Aniko
    Koever, Katalin E.
    Antus, Sandor
    Borbas, Aniko
    TETRAHEDRON, 2013, 69 (15) : 3149 - 3158
  • [49] Design of nonamidine containing inhibitors of human Factor Xa with potent anticoagulant activity.
    Masters, JJ
    Franciskovich, JB
    Tinsley, J
    Craft, TJ
    Beight, DW
    Ficorfilli, J
    Froelich, LL
    Gifford-Moore, DS
    Hay, LA
    Herron, DK
    Klimkowski, VJ
    Kurz, KD
    Mendel, D
    Ratz, AM
    Sawyer, JS
    Smith, GF
    Smith, T
    Tebbe, AL
    Towner, RD
    Weir, LC
    Wiley, MR
    Wilson, A
    Yee, YK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U35 - U36
  • [50] Apixaban, an oral direct factor Xa inhibitor, inhibits human clot-bound factor Xa activity in vitro
    Jiang, Xiaosui
    Crain, Earl J.
    Luettgen, Joseph M.
    Schumacher, William A.
    Wong, Pancras C.
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (04) : 780 - 782